+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
CORONA

Corona Remedies Share Price

 

 

Corona Remedies live price: ₹2037.9. It opened at ₹2,030 vs previous close ₹2,009; intraday high/low: ₹2,076/₹2,030. The 50 DMA stands at ₹1,776.53.

Corona Remedies Performance

  • Today's Low
  • ₹2,030
  • Today's High
  • ₹2,076
  • 52 Week Low
  • ₹1,337
  • 52 Week High
  • ₹2,101
  • Open Price₹2,030
  • Previous Close₹2,009
  • Volume47,437
  • 50 DMA₹1,776.53
  • 100 DMA₹1,676.68
  • 200 DMA-

Corona Remedies Chart

Investment Returns

  • Over 1 Month + 19.84%
  • Over 3 Month + 35.93%
  • Over 6 Month + 41.18%
  • Over 1 Year + 91.89%

Smart Investing Starts Here Start SIP with Corona Remedies for Steady Growth!

Invest Now

Corona Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 67.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 12,464
  • P/B Ratio
  • 16.7
  • Average True Range
  • 78.42
  • EPS
  • 32.68
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 58.13
  • RSI
  • 72.6
  • MFI
  • 80.64

Latest Stock News Updates

Corona Remedies inaugurates women's hormone manufacturing facility in Ahmedabad

The integrated manufacturing unit will produce multiple dosage formsincluding tablets, soft gel capsules, ointments and gelswithin a single manufacturing ecosystem

ADIA, Aberdeen Group, others buy 7.3% stake in Corona Remedies for 777 crore

Following the stake purchase, shares of Corona Remedies rose nearly 3 per cent on Thursday to trade at 1,840 apiece on the National Stock Exchange (NSE).

Corona Remedies Results Earnings Call for Q4FY26 & Full Year

Conference Call with Corona Remedies Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

Corona Remedies Financials

Corona Remedies Technicals

EMA & SMA

Current Price
₹2,037.90
+ 28.9 (1.44%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 13
  • 20 Day
  • ₹1,875.30
  • 50 Day
  • ₹1,776.50
  • 100 Day
  • ₹1,676.70
  • 200 Day
  • -

Resistance and Support

2047.93 Pivot Speed
  • R3 2,111.77
  • R2 2,093.83
  • R1 2,065.87
  • S1 2,019.97
  • S2 2,002.03
  • S3 1,974.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Corona Remedies Limited is a fast-growing Indian pharmaceutical company focused on women’s healthcare, cardio-diabeto, pain management, and urology. It operates two manufacturing facilities in Gujarat and Himachal Pradesh with 11 production lines and EU-GMP/WHO-GMP certifications.

Corona Remedies Ltd has an operating revenue of Rs. 1,403.18 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 17% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 25% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 89 which is a GOOD score indicating consistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Corona Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-11 Audited Results & Final Dividend
2026-02-02 Quarterly Results
2026-01-02 Quarterly Results Inter-alia, to consider and approve the financial results for the period ended September 30, 2025 per share(100%)Final Dividend
Date Purpose Remarks
2026-06-19 FINAL Rs.10.00 per share(100%)Final Dividend
View Corona Remedies Dividend History Arrow

Corona Remedies Shareholding Pattern

69%
6.35%
0.58%
2.25%
0%
0.77%
21.05%

Corona Remedies FAQs

Corona Remedies share price is ₹2,037 As on 03 July, 2026 | 23:31

The Market Cap of Corona Remedies is ₹12463.8 Cr As on 03 July, 2026 | 23:31

The P/E ratio of Corona Remedies is 67.3 As on 03 July, 2026 | 23:31

The PB ratio of Corona Remedies is 16.7 As on 03 July, 2026 | 23:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23